While prior research supports roles for IL-17A+ lymphocytes and activated γδ T cells as key drivers of inflammation in preterm infants (22–26), little is known about the contribution of IL-17a-producing cells in BPD pathogenesis. Here, IL17A is linked to bronchopulmonary dysplasia.